fashion -WSS

fashion

author：comprehensive 2025-09-29 19:59:52 - browse：87

Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.

The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”

Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： House panel to mark up pandemic

WSS

Evacuations in place as 3 wildfires burn in eastern Washington state

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

US intelligence assessment says Iran not currently developing nuclear weapons

An interview with Robert F. Kennedy Jr. on vaccines

FDA approves first treatment for ultra

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

focus

fashion

hotspot

Walensky prepares to leave CDC — and Congress — behind

What to know about a major upcoming Wegovy heart health study

Wildfire smoke exposes gaps in outdoor worker protections

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Malaria cases in Florida and Texas: Here’s what you need to know

An interview with Robert F. Kennedy Jr. on vaccines

Apple is now the first public company to be valued at $3 trillion

How corporate America is slashing DEI workers amid backlash to diversity programs

Duchenne breakthrough therapy leaves behind pioneering families

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

explore

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

ActiGraph execs on goal of drug approvals with digital endpoints

FDA approves Leqembi, a milestone in Alzheimer’s treatment

US intelligence assessment says Iran not currently developing nuclear weapons

Clinical trials must include more disabled people

FDA approves first treatment for ultra

focus

entertainment

Wikipedia

hotspot